
    
      Gleevec will be administered at a dose of 400 mg orally once daily.

      Patients will continue to receive the drug until either drug progression or the development
      of intolerable side effects.

      Patients will be assessed with a complete blood count weekly for the first 8 weeks and will
      have monthly physical examinations and bone marrow examinations every 3 months.
    
  